Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging biomarkers for improving pregnancy planning in multiple sclerosis.
Cuello JP, Meldaña Rivera A, Monreal E, Gómez Lozano A, García Cano AM, García Domínguez JM, Fernández Velasco JI, Costa-Frossard França L, Goicochea H, Higueras Y, De León-Luis JA, Sainz De La Maza S, Villarrubia N, Arribas Gómez I, Ruiz Perez I, Martinez Ginés ML, Villar LM. Cuello JP, et al. Among authors: sainz de la maza s. Front Neurol. 2024 Feb 15;15:1292296. doi: 10.3389/fneur.2024.1292296. eCollection 2024. Front Neurol. 2024. PMID: 38426179 Free PMC article.
Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study.
Costa-Frossard França L, Meca Lallana V, Labiano-Fontcuberta A, Blasco R, Monreal E, Martínez Ginés ML, Aguirre C, Sabin Muñoz J, Sainz de la Maza S, Cuello JP, Díaz-Pérez C, Chico García JL, Lozano Ros A, Rodríguez Jorge F, Martínez Martínez S, García Domínguez JM. Costa-Frossard França L, et al. Among authors: sainz de la maza s. CNS Drugs. 2024 Mar;38(3):231-238. doi: 10.1007/s40263-024-01066-3. Epub 2024 Feb 28. CNS Drugs. 2024. PMID: 38418770 Free PMC article.
Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.
Monreal E, Fernández-Velasco JI, García-Soidán A, Sainz de la Maza S, Espiño M, Villarrubia N, Rodríguez-Jorge F, Chico-García JL, Sainz-Amo R, Masjuan J, Costa-Frossard L, Villar LM. Monreal E, et al. Among authors: sainz de la maza s. Front Immunol. 2023 Oct 25;14:1288169. doi: 10.3389/fimmu.2023.1288169. eCollection 2023. Front Immunol. 2023. PMID: 37954589 Free PMC article.
Abnormal functional connectivity in radiologically isolated syndrome: A resting-state fMRI study.
Benito-León J, Del Pino AB, Aladro Y, Cuevas C, Domingo-Santos Á, Galán Sánchez-Seco V, Labiano-Fontcuberta A, Gómez-López A, Salgado-Cámara P, Costa-Frossard L, Monreal E, Sainz de la Maza S, Matías-Guiu JA, Matías-Guiu J, Delgado-Álvarez A, Montero-Escribano P, Martínez-Ginés ML, Higueras Y, Ayuso-Peralta L, Malpica N, Melero H. Benito-León J, et al. Among authors: sainz de la maza s. Mult Scler. 2023 Oct;29(11-12):1393-1405. doi: 10.1177/13524585231195851. Epub 2023 Sep 29. Mult Scler. 2023. PMID: 37772510 Free PMC article.
Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine.
Rodero-Romero A, Sainz de la Maza S, Fernández-Velasco JI, Monreal E, Walo-Delgado PE, Chico-García JL, Villarrubia N, Rodríguez-Jorge F, Rodríguez-Ramos R, Masjuan J, Costa-Frossard L, Villar LM. Rodero-Romero A, et al. Among authors: sainz de la maza s. Vaccines (Basel). 2023 Aug 22;11(9):1399. doi: 10.3390/vaccines11091399. Vaccines (Basel). 2023. PMID: 37766078 Free PMC article.
Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis.
Sainz de la Maza S, Maurino J, Castillo-Triviño T, Borges M, Sebastián Torres B, Sotoca J, Alonso Torres AM, Caminero AB, Borrega L, Sánchez-Menoyo JL, Barrero-Hernández FJ, Calles C, Brieva L, Blasco MR, Dotor García-Soto J, Rodríguez-Regal A, Navarro-Cantó L, Agüera-Morales E, Garcés M, Carmona O, Gabaldón-Torres L, Forero L, Hervás M, Gómez-Ballesteros R. Sainz de la Maza S, et al. Patient Prefer Adherence. 2023 Jun 14;17:1431-1439. doi: 10.2147/PPA.S411069. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37337517 Free PMC article.
Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach.
Sainz de la Maza S, Gómez-Ballesteros R, Borges M, Martín-Martínez J, Sotoca J, Alonso A, Caminero AB, Borrega L, Sánchez-Menoyo JL, Barrero-Hernández FJ, Calles C, Brieva L, Blasco-Quílez MR, Dotor García-Soto J, Del Campo-Amigo M, Navarro-Cantó L, Agüera E, Garcés-Redondo M, Carmona O, Gabaldón-Torres L, Forero L, Hervàs M, Medrano N, Maurino J, Castillo-Triviño T. Sainz de la Maza S, et al. Mult Scler J Exp Transl Clin. 2023 May 10;9(2):20552173231169475. doi: 10.1177/20552173231169475. eCollection 2023 Apr-Jun. Mult Scler J Exp Transl Clin. 2023. PMID: 37187856 Free PMC article.
Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.
Sainz de la Maza S, Walo-Delgado PE, Rodríguez-Domínguez M, Monreal E, Rodero-Romero A, Chico-García JL, Pariente R, Rodríguez-Jorge F, Ballester-González R, Villarrubia N, Romero-Hernández B, Masjuan J, Costa-Frossard L, Villar LM. Sainz de la Maza S, et al. Vaccines (Basel). 2023 Apr 3;11(4):786. doi: 10.3390/vaccines11040786. Vaccines (Basel). 2023. PMID: 37112698 Free PMC article.
47 results